Video guest: Josephine Mwangi

April 2018
26 27 28 29 30 31 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 1 2 3 4 5 6



Follow the CTA Brussels Daily


twitter logo


facebook logo cta

Tuesday, 24 April 2018
Members of Europena Parliament will vote on a consultative report from Joseph DAUL (EPP-ED, FR) for the Agriculture Committee which recommends approving unchanged a Commission proposal for the European Community to accede to the International Convention for the Protection of New Varieties of Plants, as revised at Geneva on 19 March 1991.
The main activities of the international Union for the Protection of New Varieties of Plants (UPOV) are concerned with promoting international harmonisation and cooperation in the introduction of plant variety protection legislation. Harmonisation is enhanced, firstly, through specific activities undertaken within UPOV leading to recommendations and model agreements and forms and, secondly, through the fact that UPOV serves as a forum to exchange views and share experiences. UPOV has established a detailed set of general principles for the conduct of the examination of plant varieties; their use also extends to national listing and seed certification.
Innovation Policy in Europe 2004 is the latest edition of the annual policy synthesis report of the TrendChart initiative managed by the Directorate-General for Enterprise and Industry.The report provides an overview of innovation challenges and policy trends in the 25 European Union Member States, eight Associate and Accession Countries and three economic zones namely NAFTA, MEDA and ASIA. It highlights the different key innovation policy challenges in the EU and provides examples of good policy responses. As well as providing an overview of innovation policy fields where good progress has been made towards the Lisbon objective, the report highlights what remains to be done It confirms that innovation has become a matter of high policy priority in many countries and that different approaches exist to cope with the identified policy challenges. The report will further stimulate the search for best solutions and encourage cooperation in the field of innovation policy.
Wednesday, 06 April 2005
Food and Feed Operators are reminded of their responsibilities for food safety.
The key obligations of food and feed operators when it comes to food safety have been outlined in a new leaflet by the Commission. The aim of the leaflet is to remind operators that, under EU Food Law, they have binding responsibilities for food put on the EU market. It will also provide consumers with a readable outline of what they should expect from food operators. The document sets out the obligations under seven headings:
- Safety
- Responsibility
- Traceability
- Transparency
- Emergency
- Prevention
- Cooperation
As the internet develops from an information source to a place for e-transactions, European researchers are exploring the psychological impact of websites and why people trust one site over another. One such study, by British psychologists, explores how trustworthy people find different health advice websites.Psychologists in Europe are discovering what people look for when deciding whether or not a website offers trustworthy health advice and why people sometimes reject advice from some of the better-known sources.
In a project supported by the UK’s Economic and Social Research Council (ESRC) – a research funding and training agency – under its e-Society initiative, researchers from different universities in England studied the internet habits of 15 women who were considering taking hormone replacement therapy over a period of six months.The study, carried out by Professor Pamela Briggs and Dr Liz Sillence of Northumbria University’s PACT Lab, together with colleagues at both Northumbria and Sheffield Universities, is being presented, in the first week of April, at the British Psychological Society (BPS) Conference at the University of Manchester.
ropean Medicines Agency (EMEA) is a decentralised body of the European Union with headquarters in London.
Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use. The EMEA coordinates the evaluation and supervision of medicinal products throughout the European Union. The Agency brings together the scientific resources of the 25 EU Member States in a network of 42 national competent authorities. It cooperates closely with international partners, reinforcing the EU contribution to global harmonisation.
In 2001, the Committee on Orphan Medicinal Products (COMP) was established, charged with reviewing designation applications from persons or companies who intend to develop medicines for rare diseases (so-called ‘orphan drugs’). The Committee on Herbal Medicinal Products (HMPC) was established in 2004 and provides scientific opinions on traditional herbal medicines.A network of some 3,500 European experts underpins the scientific work of the EMEA anA new section of the EMEA website has been created to highlight the Agency's activities relating to its implementation of the new EU pharmaceutical legislation. The section provides overview information and a release schedule for documents and guidelines being drafted during the year as part of the implementation process. EMEA stakeholders and interested parties will be requested to provide their comments on these draft documents and guidelines during the consultation periods specified. Consultations are expected to start from March 2005.